Thu. 9 May 2024, 9:05am ET
Benzinga
Earnings, Earnings Beats, News
Edgewise Therapeutics (NASDAQ:EWTX) reported quarterly losses of $(0.33) per share which beat the analyst consensus estimate of $(0.39) by 15.38 percent. This is a 8.33 percent increase over losses of $(0.36) per share from the same period last year.